Chikungunya antibody set to enter clinical trial
![](https://familymednews.com/wp-content/uploads/sites/15/2019/02/cfarmafotochikungunya-616x280.jpg)
A monoclonal antibody against the chikungunya virus developed by researchers at Vanderbilt University Medical Center is the first monoclonal antibody encoded by messenger RNA to enter a clinical trial. Moderna Inc., a biotechnology firm based in Cambridge, Massachusetts, that is focused on developing mRNA-based vaccines and therapeutics, announced the clinical trial earlier this month. The specific antibody against the mosquito-borne […]
Continue reading »